James Wooldridge

James Wooldridge, M.D. is an accomplished medical professional with extensive experience in oncology and immuno-oncology. Currently serving as Chief Medical Officer at Immunitas Therapeutics and JWMD Consulting, LLC, James has previously held the position of Chief Medical Officer at Checkmate Pharmaceuticals and Aeglea BioTherapeutics. James also contributed to Eli Lilly and Company as Chief Scientific Officer for Immuno-Oncology Clinical Development and held several senior roles in oncology medical affairs. James completed a fellowship in Medical Oncology and served as Chief Resident in Internal Medicine at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.